Affinity Biosensors Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.73M

  • Investors
  • 4

Affinity Biosensors General Information

Description

Developer of an antimicrobial susceptibility testing device designed to provide a rapid way to measure and observe growth and response. The company's device can be used for cell counting, and visual observation of liquid samples, helping healthcare professionals in the measurement of mass in fluid, with femtogram resolution, and detecting positive growth.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 222 East Canon Perdido Street
  • Suite 101
  • Santa Barbara, CA 93101
  • United States
+1 (860) 000-0000
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 222 East Canon Perdido Street
  • Suite 101
  • Santa Barbara, CA 93101
  • United States
+1 (860) 000-0000

Affinity Biosensors Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Affinity Biosensors Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 11-Jun-2024 $3.73M 000.00 Completed Generating Revenue
11. Later Stage VC (Series A) 22-Mar-2024 00.00 000.00 Completed Generating Revenue
10. Later Stage VC (Series A) 17-Nov-2021 00.00 0000 Completed Generating Revenue
9. Later Stage VC (Series A3) 03-Feb-2020 00.000 000.00 Completed Generating Revenue
8. Later Stage VC (Series A2) 17-Dec-2018 00.000 000.00 Completed Generating Revenue
7. Later Stage VC (Series A2) 23-Aug-2016 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series A2) 09-Feb-2015 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 23-Dec-2013 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 19-Jul-2011 $1.52M $1.82M Completed Generating Revenue
3. Grant 01-Jan-2009 $899K $300K Completed Generating Revenue
To view Affinity Biosensors’s complete valuation and funding history, request access »

Affinity Biosensors Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an antimicrobial susceptibility testing device designed to provide a rapid way to measure and observe growt
Diagnostic Equipment
Santa Barbara, CA
25 As of 2024
000.00
0000000000 0 000.00

000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
0000000000 000000000
Depew, NY
000 As of 0000
00000 0000-00-00
000000&0

000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
00000 0000000 000 00
Munich, Germany
00 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Affinity Biosensors Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Reichert Formerly PE-Backed Depew, NY 000 000000&0
Nanion Technologies Accelerator/Incubator Backed Munich, Germany 00 000000000000
Dynamic Biosensors Venture Capital-Backed Munich, Germany 00 000.00 000000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Affinity Biosensors Patents

Affinity Biosensors Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9835614-B2 Measurement of cell growth and drug susceptibility by resonant mass measurement Active 09-Sep-2013 00000000000 0
US-20150072373-A1 Measurement of cell growth and drug susceptibility by resonant mass measurement Active 09-Sep-2013 00000000000 0
EP-3044566-A2 Measurement of cell growth and drug susceptiblity by resonant mass measurement Active 09-Sep-2013 00000000000
EP-3044566-B1 Measurement of cell growth and drug susceptiblity by resonant mass measurement Active 09-Sep-2013 00000000000
US-20140345369-A1 System and method for measuring viscosity using particle transit time in resonant microfluidic channels Inactive 01-May-2013 G01N11/10 0
To view Affinity Biosensors’s complete patent history, request access »

Affinity Biosensors Executive Team (5)

Name Title Board Seat
Kenneth Babcock Ph.D Co-Founder, Chief Executive Officer, Manager and Board Member
Steve Markakis Chief Operating Officer
John Foster Co-Founder
Scott Manalis Ph.D Co-Founder
L. Robert Johnson Manager & Board Member
To view Affinity Biosensors’s complete executive team members history, request access »

Affinity Biosensors Board Members (2)

Name Representing Role Since
James Iuliano Affinity Biosensors Board Member 000 0000
L. Robert Johnson Affinity Biosensors Manager & Board Member 000 0000
To view Affinity Biosensors’s complete board members history, request access »

Affinity Biosensors Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Affinity Biosensors Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Rose Ventures Venture Capital Minority 000 0000 000000 0
Founders Capital Partners Angel Group Minority 000 0000 000000 0
National Institute of Standards and Technology Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view Affinity Biosensors’s complete investors history, request access »

Affinity Biosensors Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Travera 16-Jun-2018 00000 0000 00.000 Biotechnology
Travera 20-Feb-2018 Early Stage VC 00000 Biotechnology
To view Affinity Biosensors’s complete investments history, request access »

Affinity Biosensors FAQs

  • When was Affinity Biosensors founded?

    Affinity Biosensors was founded in 2006.

  • Who is the founder of Affinity Biosensors?

    John Foster and Scott Manalis Ph.D are the founders of Affinity Biosensors.

  • Who is the CEO of Affinity Biosensors?

    Kenneth Babcock Ph.D is the CEO of Affinity Biosensors.

  • Where is Affinity Biosensors headquartered?

    Affinity Biosensors is headquartered in Santa Barbara, CA.

  • What is the size of Affinity Biosensors?

    Affinity Biosensors has 25 total employees.

  • What industry is Affinity Biosensors in?

    Affinity Biosensors’s primary industry is Diagnostic Equipment.

  • Is Affinity Biosensors a private or public company?

    Affinity Biosensors is a Private company.

  • What is Affinity Biosensors’s current revenue?

    The current revenue for Affinity Biosensors is 000000.

  • How much funding has Affinity Biosensors raised over time?

    Affinity Biosensors has raised $70.2M.

  • Who are Affinity Biosensors’s investors?

    Rose Ventures, Founders Capital Partners, National Institute of Standards and Technology, and National Science Foundation have invested in Affinity Biosensors.

  • Who are Affinity Biosensors’s competitors?

    Reichert, Nanion Technologies, and Dynamic Biosensors are competitors of Affinity Biosensors.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »